AFIB Acutus Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AFIB

Price (delayed)

$0.2401

Market cap

$7.04M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.12

Enterprise value

$14.85M

Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique ...

Highlights
The EPS has soared by 64% YoY and by 19% from the previous quarter
AFIB's net income has soared by 62% YoY and by 18% QoQ
Acutus Medical's equity has decreased by 45% YoY and by 28% QoQ
Acutus Medical's quick ratio has decreased by 2.9% QoQ and by 2.9% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.acutusmedical.com
Peers: PDEX OFIX NVRO

Key stats

What are the main financial stats of AFIB
Market
Shares outstanding
29.3M
Market cap
$7.04M
Enterprise value
$14.85M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.22
Price to sales (P/S)
0.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.76
Earnings
Revenue
$19.66M
EBIT
-$27.18M
EBITDA
-$21.4M
Free cash flow
-$60.99M
Per share
EPS
-$1.12
Free cash flow per share
-$2.08
Book value per share
$1.08
Revenue per share
$0.67
TBVPS
$2.85
Balance sheet
Total assets
$84.73M
Total liabilities
$53.02M
Debt
$38.93M
Equity
$31.71M
Working capital
$57.87M
Liquidity
Debt to equity
1.23
Current ratio
4.92
Quick ratio
3.69
Net debt/EBITDA
-0.37
Margins
EBITDA margin
-108.8%
Gross margin
-61.6%
Net margin
-166.8%
Operating margin
-155.5%
Efficiency
Return on assets
-30.2%
Return on equity
-62.2%
Return on invested capital
-27.8%
Return on capital employed
-38.9%
Return on sales
-138.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AFIB stock price

How has the Acutus Medical stock price performed over time
Intraday
-3.22%
1 week
-5.4%
1 month
-52.08%
1 year
-70.36%
YTD
-79.12%
QTD
-65.53%

Financial performance

How have Acutus Medical's revenue and profit performed over time
Revenue
$19.66M
Gross profit
-$12.11M
Operating income
-$30.57M
Net income
-$32.79M
Gross margin
-61.6%
Net margin
-166.8%
The net margin has surged by 69% year-on-year and by 25% since the previous quarter
Acutus Medical's operating margin has surged by 67% YoY and by 26% QoQ
AFIB's net income has soared by 62% YoY and by 18% QoQ
The operating income has soared by 58% YoY and by 19% from the previous quarter

Growth

What is Acutus Medical's growth rate over time

Valuation

What is Acutus Medical stock price valuation
P/E
N/A
P/B
0.22
P/S
0.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.76
The EPS has soared by 64% YoY and by 19% from the previous quarter
The price to book (P/B) is 56% lower than the last 4 quarters average of 0.5
Acutus Medical's equity has decreased by 45% YoY and by 28% QoQ
AFIB's P/S is 74% below its last 4 quarters average of 1.4
AFIB's revenue is up by 25% year-on-year and by 9% since the previous quarter

Efficiency

How efficient is Acutus Medical business performance
The ROS has soared by 73% YoY and by 28% from the previous quarter
AFIB's return on invested capital has surged by 56% year-on-year and by 16% since the previous quarter
The company's return on assets has surged by 51% YoY and by 12% QoQ
AFIB's ROE is up by 44% YoY and by 8% from the previous quarter

Dividends

What is AFIB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AFIB.

Financial health

How did Acutus Medical financials performed over time
Acutus Medical's total assets is 60% higher than its total liabilities
Acutus Medical's total assets has decreased by 26% YoY and by 16% QoQ
Acutus Medical's total liabilities has decreased by 7% YoY and by 6% QoQ
The debt is 23% greater than the equity
The company's debt to equity has surged by 84% YoY and by 38% QoQ
Acutus Medical's equity has decreased by 45% YoY and by 28% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.